MedTrace Logo

CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms

NCT03844334 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2024-01-24

No results posted yet for this study

Summary

The study is an observational, European, multi-center, prospective assessment of the clinical utility of the 0.017 WEB Aneurysm Embolization System in subjects with intracranial aneurysms deemed appropriate for endovascular treatment.

Conditions

  • Brain Aneurysm

Interventions

DEVICE

WEB Aneurysm Embolization System

Subjects aged ≥ 18 years, but ≤ 80 years requiring treatment for single ruptured or unruptured intracranial aneurysms.

Sponsors & Collaborators

  • Microvention-Terumo, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-21
Primary Completion
2022-08-30
Completion
2022-08-30

Countries

  • France
  • Germany
  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03844334 on ClinicalTrials.gov